Ceralasertib (AZD6738), an oral ATR kinase inhibitor, in combination with carboplatin in patients with advanced solid tumors: a Phase I study

Timothy Yap, Matthew Krebs, Sophie Postel-Vinay, Anthony El-Khouiery, Jean-Charles Soria, Juanita Lopez, Alienor Berges, S. Y. Amy Cheung, Itziar Irurzan-Arana, Andrew Goldwin, Brunella Felicetti, Gemma Jones, Alan Lau, Paul Frewer, Andrew Pierce, Glen Clack, Christine Stephens, Simon Smith, Emma Jane Dean, Simon J. Hollingsworth

Research output: Contribution to journal › Article › peer-review

226 Downloads (Pure)

Fingerprint

Dive into the research topics of 'Ceralasertib (AZD6738), an oral ATR kinase inhibitor, in combination with carboplatin in patients with advanced solid tumors: a Phase I study'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science